Consolidated Statements of Operations (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Net sales	$ 847,834	$ 91,873
Cost of sales	603,006	86,327
Gross profit	244,828	5,546
Research and development costs	44,090	45,578
Selling, general and administrative expenses (including share based compensation of $914,479 and $611,500, respectively)	6,491,671	5,590,867
Loss from operations	(6,290,933)	(5,630,899)
Other income (expense)
Gain incurred in connection with troubled debt restructuring, net	46,978	0
Amortization of debt discount	(444,450)	(255,583)
Loss from warrants/derivatives issued with debt greater than debt carrying value	0	(736,000)
(Loss) gain on fair market valuation of derivatives	(91,000)	870,000
Interest and financing expense, net	(760,132)	(733,495)
Other income (expense), net	(1,248,604)	(855,078)
Net loss before taxes	(7,539,537)	(6,485,977)
Benefit from sale of state net operating loss credits	3,351,645	2,209,715
Net loss	(4,187,892)	(4,276,262)
Preferred dividend	1,560,200	1,175,350
Net loss applicable to common shareholders	$ (5,748,092)	$ (5,451,612)
Net loss per share attributable to common shareholders - basic and diluted	$ (0.10)	$ (0.15)
Weighted average number of common shares outstanding - basic and diluted	55,307,453	37,314,265